Lessons from experimental Mycobacterium tuberculosis infections

Microbes and Infection

Volumn 8, Issue 4, 2006, Pages 1179-1188

  Flynn, JoAnne L ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Animal model; Genetic deficiency; Immunoregulation; Murine model; Mycobacterium tuberculosis

Indexed keywords

BACTERIAL COUNT; BACTERIAL STRAIN; DATA ANALYSIS; DISEASE MODEL; DNA MODIFICATION; GENETIC DISORDER; GRANULOMA; GUINEA PIG; IMMUNE RESPONSE; IMMUNOPATHOGENESIS; IMMUNOREGULATION; KNOCKOUT MOUSE; MEDICAL RESEARCH; MONKEY; MYCOBACTERIOSIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROPHYLAXIS; RABBIT; SHORT SURVEY; TUBERCULOSIS;

ANIMALS; CELL COUNT; CYTOKINES; DISEASE MODELS, ANIMAL; FISHES; GUINEA PIGS; HAPLORHINI; HUMANS; LUNG; MICE; MICE, KNOCKOUT; MYCOBACTERIUM TUBERCULOSIS; PRIMATES; RABBITS; SPECIES SPECIFICITY; T-LYMPHOCYTE SUBSETS; TIME FACTORS; TUBERCULOSIS;

ANIMALIA; BACTERIA (MICROORGANISMS); CAVIA PORCELLUS; MURINAE; MYCOBACTERIUM TUBERCULOSIS; ORYCTOLAGUS CUNICULUS;

EID: 33646143975     PISSN: 12864579     EISSN: 1769714X     Source Type: Journal    
DOI: 10.1016/j.micinf.2005.10.033     Document Type: Short Survey

References (78)

1. Lazarevic V., Nolt D., and Flynn J.L. Long-term control of Mycobacterium tuberculosis infection is mediated by dynamic immune responses. J. Immunol. 175 (2005) 1107
2. Chackerian A.A., Alt J.M., Perera T.V., Dascher C.C., and Behar S.M. Dissemination of Mycobacterium tuberculosis is influenced by host factors and precedes the initiation of T-cell immunity. Infect. Immun. 70 (2002) 4501
3. Lazarevic V., Myers A.J., Scanga C.A., and Flynn J.L. CD40, but not CD40L, is required for the optimal priming of T cells and control of aerosol M. tuberculosis infection. Immunity 19 (2003) 823
4. Rhoades E.R., Frank A.A., and Orme I.M. Progression of chronic pulmonary tuberculosis in mice aerogenically infected with virulent Mycobacterium tuberculosis. Tubercle Lung Dis. 78 (1997) 57
5. Munoz-Elias E.J., Timm J., Botha T., Chan W.T., Gomez J.E., and McKinney J.D. Replication dynamics of Mycobacterium tuberculosis in chronically infected mice. Infect. Immun. 73 (2005) 546
6. Rees R.J.W., and Hart D. Analysis of the host-parasite equilibrium in chronic murine tuberculosis by total and viable bacillary counts. Br. J. Exp. Pathol. 42 (1961) 83
7. Lazarevic V., Yankura D.J., DiVito S.J., and Flynn J.L. Induction of Mycobacterium tuberculosis-specific primary and secondary T-cell responses in interleukin-15-deficient mice. Infect. Immun. 73 (2005) 2910
8. Flynn J.L., and Chan J. Tuberculosis: latency and reactivation. Infect. Immun. 69 (2001) 4195
9. McCune R.M., Tompsett R., and McDermott W. The fate of Mycobacterium tuberculosis in mouse tissues as determined by the microbial enumeration technique. II. The conversion of tuberculous infection to the latent state by the administration of pyrazinamide and a companion drug. J. Exp. Med. 104 (1957) 763
10. Lowrie D.B., Tascon R.E., Bonato V.L.D., Lima V.M.F., Faccioli L.H., Stavropoulos E., Colston M.J., Hewinson R.G., Moelling K., and Silva C.L. Therapy of tuberculosis in mice by DNA vaccination. Nature 400 (1999) 269
11. Scanga C.A., Mohan V.P., Joseph H., Yu K., Chan J., and Flynn J. Reactivation of latent tuberculosis: variations on the Cornell murine model. Infect. Immun. 67 (1999) 4531
12. McMurray D. Disease model: pulmonary tuberculosis. Trends Mol. Med. 7 (2001) 135
13. Jeevan A., Yoshimura T., Foster G., and McMurray D.N. Effect of Mycobacterium bovis BCG vaccination on interleukin-1β and RANTES mRNA expression in guinea pig cells exposed to attenuated and virulent mycobacteria. Infect. Immun. 70 (2002) 1245
14. Cho H., Lasco T.M., Allen S.S., Yoshimura T., and McMurray D.N. Recombinant guinea pig tumor necrosis factor alpha stimulates the expression of interleukin-12 and the inhibition of Mycobacterium tuberculosis growth in macrophages. Infect. Immun. 73 (2005) 1367
15. Skwor T.A., Cho H., Cassidy C., Yoshimura T., and McMurray D.N. Recombinant guinea pig CCL5 (RANTES) differentially modulates cytokine production in alveolar and peritoneal macrophages. J. Leukoc. Biol. 76 (2004) 1229
16. Allison M.J., Zappasodi P., and Lurie M.B. Host-parasite relationships in natively resistant and susceptible rabbits on quantitative inhalation of tubercle bacilli. Their significance for the nature of genetic resistance. Am. Rev. Respir. Dis. 85 (1962) 553
17. Bishai W.R., Dannenberg Jr. A.M., Parrish N., Ruiz R., Chen P., Zook B.C., Johnson W., Boles J.W., and Pitt M.L. Virulence of Mycobacterium tuberculosis CDC1551 and H37Rv in rabbits evaluated by Lurie's pulmonary tubercle count method. Infect. Immun. 67 (1999) 4931
18. Tsenova L., Ellison E., Harbacheuski R., Moreira A.L., Kurepina N., Reed M.B., Mathema B., Barry III C.E., and Kaplan G. Virulence of selected Mycobacterium tuberculosis clinical isolates in the rabbit model of meningitis is dependent on phenolic glycolipid produced by the bacilli. J. Infect. Dis. 192 (2005) 98
19. Converse P.J., Dannenberg A.M., Estep J.E., Sugisaki K., Abe Y., Schofield B.H., and Pitt M.L.M. Cavitary tuberculosis produced in rabbits by aerosolized virulent tubercle bacilli. Infect. Immun. 64 (1996) 4776
20. Dannenberg A.M.J. Pathogenesis of pulmonary Mycobacterium bovis infection: basic principles established by the rabbit model. Tuberculosis 81 (2001) 87
21. Converse P.J., Dannenberg A.M., Shigenaga T., McMurray D.N., Phalen S.W., Stanford J.L., Rook G.A.W., Koru-Sengul T., Abbey H., Estep J.E., and Pitt M.L.M. Pulmonary bovine-type tuberculosis in rabbits: bacillary virulence, inhaled dose effects, tuberculin sensitivity, and Mycobacterium vaccae immunotherapy. Clin. Diagn. Lab. Immunol. 5 (1998) 871
22. Manabe Y.C., Dannenberg Jr. A.M., Tyagi S.K., Hatem C.L., Yoder M., Woolwine S.C., Zook B.C., Pitt M.L., and Bishai W.R. Different strains of Mycobacterium tuberculosis cause various spectrums of disease in the rabbit model of tuberculosis. Infect. Immun. 71 (2003) 6004
23. Tsenova L., Sokol K., Freedman V.H., and Kaplan G. 1998. A combination of thalidomide plus antibiotics protects rabbits from mycobacterial meningitis-associated death. J. Infect. Dis. 177 (1563)
24. Tsenova L., Bergtold A., Freedman V.H., Young R.A., and Kaplan G. Tumor necrosis factor alpha is a determinant of pathogenesis and disease progression in mycobacterial infection in the central nervous system. Proc. Natl. Acad. Sci. U.S.A. 96 (1999) 5657
25. Good R.C. Simian tuberculosis: immunologic aspects. Ann. N.Y. Acad. Sci. 154 (1968) 200
26. Barclay W.R., Busey W.M., Dalgard D.W., Good R.C., Janick R.W., Kasik J.E., Ribi E., Ulrich C.E., and Wolinsky E. Protection of monkeys against airborne tuberculosis by aerosol vaccination with Bacillus Calmette-Guerin. Am. Rev. Respir. Dis. 107 (1973) 351
27. Langermans J.A.M., Andersen P., van Soolingen D., Vervenne R.A.W., Frost P.A., van der Laan T., van Pinsteren L.A.H., van den Hombergh J., Kroom S., Peekel I., Florquin S., and Thomas A.W. Divergent effect of bacillus Calmette-Guerin (BCG) vaccination on Mycobacterium tuberculosis infection in highly related macaque species: Implications for primate models in tuberculosis vaccine research. Proc. Natl. Acad. Sci. U.S.A. 98 (2001) 11497
28. Shen Y., Zhou D., Chalifoux L., Shen L., Simon M., Zeng X., Lai X., Li Y., Sehgal P., Letvin N.L., and Chen Z.W. Induction of an AIDS virus-related tuberculosis-like disease in macaques: a model of simian immunodeficiency virus-mycobacterium coinfection. Infect. Immun. 70 (2002) 869
29. Shen Y., Shen L., Sehgal P., Zhou D., Simon M., Miller M., Enimi E.A., Henckler B., Chalifoux L., Sehgal N., Gastron M., Letvin N.L., and Chen Z.W. Antiretroviral agents restore Mycobacterium-specific T-cell immune responses and facilitate controlling a fatal tuberculosis-like disease in macaques coinfected with simian immunodeficiency virus and Mycobacterium bovis BCG. J. Virol. 75 (2001) 8690
30. Capuano S.V.I., Croix D.A., Pawar S., Zinovik A., Myers A., Lin P.L., Bissel S., Fuhrman C., Klein E., and Flynn J.L. Experimental Mycobacterium tuberculosis infection of cynomolgus macaques closely resembles the various manifestations of human M. tuberculosis infection. Infect. Immun. 71 (2003) 5831
31. Gormus B.J., Blanchard J.L., Alvarez X.H., and Didier P.J. Evidence for a rhesus monkey model of asymptomatic tuberculosis. J. Med. Primatol. 33 (2004) 134
32. Safi H., Gormus B.J., Didier P.J., Blanchard J.L., Lakey D.L., Martin L.N., Murphey-Corb M., Vankayalapati R., and Barnes P.F. Spectrum of manifestations of Mycobacterium tuberculosis infection in primates infected with SIV. AIDS. Res. Hum. Retroviruses 19 (2003) 585
33. Langermans J.A., Doherty T.M., Vervenne R.A., van der Laan T., Lyashchenko K., Greenwald R., Agger E.M., Aagaard C., Weiler H., van Soolingen D., Dalemans W., Thomas A.W., and Andersen P. Protection of macaques against Mycobacterium tuberculosis infection by a subunit vaccine based on a fusion protein of antigen 85B and ESAT-6. Vaccine 23 (2005) 2740
34. Wolf R.H., Gibson S.V., Watson E.A., and Baskin G.B. Multidrug chemotherapy of tuberculosis in rhesus monkeys. Lab. Anim. Sci. 38 (1988) 25
35. Talaat A.M., Reimschuessel R., Wasserman S.S., and Trucksis M. Goldfish, Carassius auratus, a novel animal model for the study of Mycobacterium marinum pathogenesis. Infect. Immun. 66 (1998) 2938
36. Bouley D.M., Ghori N., Mercer K.L., Falkow S., and Ramakrishnan L. Dynamic nature of host-pathogen interactions in Mycobacterium marinum granulomas. Infect. Immun. 69 (2001) 7820
37. Ramakrishnan L., Valdivia R.H., McKerrow J.H., and Falkow S. Mycobacterium marinum causes both long-term subclinical infection and acute disease in the leopard frog (Rana pipiens). Infect. Immun. 65 (1997) 767
38. Ramakrishnan L., Federspeil N.A., and Falkow S. Granuloma-specific expression of Mycobacterium virulence proteins from the glycine-rich PE-PGRS family. Science 288 (2000) 1436
39. Davis J.M., Clay H., Lewis J.L., Ghori N., Herbomel P., and Ramakrishnan L. Real-time visualization of mycobacterium-macrophage interactions leading to initiation of granuloma formation in zebrafish embryos. Immunity 17 (2002) 693
40. Cosma C.L., Humbert O., and Ramakrishnan L. Superinfecting mycobacteria home to established tuberculous granulomas. Nat. Immunol. 5 (2004) 828
41. Cooper A.M., Dalton D.K., Stewart T.A., Griffen J.P., Russell D.G., and Orme I.M. Disseminated tuberculosis in IFN-γ gene-disrupted mice. J. Exp. Med. 178 (1993) 2243
42. Flynn J.L., Chan J., Triebold K.J., Dalton D.K., Stewart T.A., and Bloom B.R. An essential role for Interferon-γ in resistance to Mycobacterium tuberculosis infection. J. Exp. Med. 178 (1993) 2249
43. Flynn J.L., Goldstein M.M., Triebold K.J., Koller B., and Bloom B.R. Major histocompatibility complex class I-restricted T cells are required for resistance to Mycobacterium tuberculosis infection. Proc. Natl. Acad. Sci. U.S.A. 89 (1992) 12013
44. Rolph M.S., Raupach B., Kobernick H.H., Collins H.L., Perarnau B., Lemonnier F.A., and Kaufmann S.H. 2001. MHC class Ia-restricted T cells partially account for beta2-microglobulin-dependent resistance to Mycobacterium tuberculosis. Eur. J. Immunol. 31 (1944)
45. Schaible U.E., Collins H.L., Priem F., and Kaufmann S.H. Correction of the iron overload defect in beta-2-microglobulin knockout mice by lactoferrin abolishes their increased susceptibility to tuberculosis. J. Exp. Med. 196 (2002) 1507
46. Flynn J.L., Goldstein M.M., Chan J., Triebold K.J., Pfeffer K., Lowenstein C.J., Schreiber R., Mak T.W., and Bloom B.R. Tumor necrosis factor-alpha is required in the protective immune response against Mycobacterium tuberculosis in mice. Immunity 2 (1995) 561
47. Bean A.G.D., Roach D.R., Briscoe H., France M.P., Korner H., Sedgwick J.D., and Britton W.J. Structural deficiencies in granuloma formation in TNF gene-targeted mice underlie the heightened susceptibility to aerosol Mycobacterium tuberculosis infection, which is not compensated for by lymphotoxin. J. Immunol. 162 (1999) 3504
48. Caruso A.M., Serbina N., Klein E., Triebold K., Bloom B.R., and Flynn J.L. Mice deficient in CD4 T cells have only transiently diminished levels of IFN-γ, yet succumb to tuberculosis. J. Immunol. 162 (1999) 5407
49. Locksley R.M., Reiner S.L., Hatam F., Littman D.R., and Killeen N. Helper T cells without CD4: control of leishmaniasis in CD4-deficient mice. Science 261 (1993) 1448
50. Cooper A.M., Magram J., Ferrante J., and Orme I.M. Interleukin 12 (IL-12) is crucial to the development of protective immunity in mice intravenously infected with Mycobacterium tuberculosis. J. Exp. Med. 186 (1997) 39
51. North R.J. Mice incapable of making IL-4 and IL-10 display normal resistance in infection with Mycobacterium tuberculosis. Clin. Exp. Immunol. 113 (1998) 55
52. Lin Y., Zhang M., Hofman F.M., Gong J., and Barnes P.F. Absence of a prominent TH2 cytokine response in human tuberculosis. Infect. Immun. 64 (1996) 1351
53. van Crevel R., Karyadi E., Preyers F., Leenders M., Kullberg B.J., Nelwan R.H., and van der Meer J.W. Increased production of interleukin 4 by CD4+ and CD8+T cells from patients with tuberculosis is related to the presence of pulmonary cavities. J. Infect. Dis. 181 (2000) 1194
54. Ordway D.J., Costa L., Martins M., Silveira H., Amaral L., Arroz M.J., Ventura F.A., and Dockrell H.M. Increased Interleukin-4 production by CD8 and gammadelta T cells in health-care workers is associated with the subsequent development of active tuberculosis. J. Infect. Dis. 190 (2004) 756
55. Cooper A.M., Kipnis A., Turner J., Magram J., Ferrante J., and Orme I.M. Mice lacking bioactive IL-12 can generate protective, antigen-specific cellular responses to mycobacterial infection only if the IL-12 p40 subunit is present. J. Immunol. 168 (2002) 1322
56. Pearl J.E., Khader S.A., Solache A., Gilmartin L., Ghilardi N., deSauvage F., and Cooper A.M. IL-27 signaling compromises control of bacterial growth in mycobacteria-infected mice. J. Immunol. 173 (2004) 7490
57. Holscher C., Holscher A., Ruckerl D., Yoshimoto T., Yoshida H., Mak T., Saris C., and Ehlers S. The IL-27 receptor chain WSX-1 differentially regulates antibacterial immunity and survival during experimental tuberculosis. J. Immunol. 174 (2005) 3534
58. Nolt D., and Flynn J.L. Interleukin-12 therapy reduces the number of immune cells and pathology in lungs of mice infected with Mycobacterium tuberculosis. Infect. Immun. 72 (2004) 2976
59. Holscher C., Atkinson R.A., Arendse B., Brown N., Myburgh E., Alber G., and Brombacher F. A protective and agonistic function of IL-12p40 in mycobacterial infection. J. Immunol. 167 (2001) 6957
60. Mohan V.P., Scanga C.A., Yu K., Scott H.M., Tanaka K.E., Tsang E., Tsai M.C., Flynn J.L., and Chan J. 2001. Effects of tumor necrosis factor alpha on host immune response in chronic persistent tuberculosis: possible role for limiting pathology. Infect. Immun. 69 (1847)
61. Turner J., Gonzalez-Juarrero M., Ellis D.L., Basaraba R.J., Kipnis A., Orme I.M., and Cooper A.M. In vivo IL-10 production reactivates chronic pulmonary tuberculosis in C57BL/6 mice. J. Immunol. 169 (2002) 6343
62. Adams L.B., Mason C.M., Kolls J.K., Scollard D., Krahenbuhl J.L., and Nelson S. Exacerbation of acute and chronic murine tuberculosis by administration of a tumor necrosis factor receptor-expressing adenovirus. J. Infect. Dis. 171 (1995) 400
63. Algood H.M., Lin P.L., Yankura D., Jones A., Chan J., and Flynn J.L. TNF influences chemokine expression of macrophages in vitro and that of CD11b+ cells in vivo during Mycobacterium tuberculosis infection. J. Immunol. 172 (2004) 6846
64. Algood H.M., Chan J., and Flynn J.L. Chemokines and tuberculosis. Cytokine Growth Factor Rev. 14 (2003) 467
65. Campos-Neto A., Ovendale P., Bement T., Koppi T.A., Fanslow W.C., Rossi M.A., and Alderson M.R. CD40 ligand is not essential for the development of cell-mediated immunity and resistance to Mycobacterium tuberculosis. J. Immunol. 160 (1998) 2037
66. Wang Y., Kelly C.G., Karttunen J.T., Whittall T., Lehner P.J., Duncan L., MacAry P., Younson J.S., Singh M., Oehlmann W., Cheng G., Bergmeier L., and Lehner T. CD40 is a cellular receptor mediating mycobacterial heat shock protein 70 stimulation of CC-chemokines. Immunity 15 (2001) 971
67. Wang Y., Kelly C.G., Singh M., McGowan E.G., Carrara A.S., Bergmeier L.A., and Lehner T. Stimulation of Th1-polarizing cytokines, C-C chemokines, maturation of dendritic cells, and adjuvant function by the peptide binding fragment of heat shock protein 70. J. Immunol. 169 (2002) 2422
68. Wang Y., Whittall T., McGowan E., Younson J., Kelly C., Bergmeier L.A., Singh M., and Lehner T. Identification of stimulating and inhibitory epitopes within the heat shock protein 70 molecule that modulate cytokine production and maturation of dendritic cells. J. Immunol. 174 (2005) 3306
69. Peters W., Scott H.M., Chambers H.F., Flynn J.L., Charo I.F., and Ernst J.D. Chemokine receptor 2 serves an early and essential role in resistance to Mycobacterium tuberculosis. Proc. Natl. Acad. Sci. U.S.A. 98 (2001) 7958
70. Scott H.M., and Flynn J.L. Mycobacterium tuberculosis in chemokine receptor 2-deficient mice: influence of dose on disease progression. Infect. Immun. 70 (2002) 5946
71. Manca C., Tsenova L., Bergtold A., Freeman S., Tovey M., Musser J.M., Barry III C.E., Freedman V.H., and Kaplan G. Virulence of a Mycobacterium tuberculosis clinical isolate in mice is determined by failure to induce Th1 type immunity and is associated with induction of IFN-alpha/beta. Proc. Natl. Acad. Sci. U.S.A. 98 (2001) 5752
72. Reed M.B., Domenech P., Manca C., Su H., Barczak A.K., Kreiswirth B.N., Kaplan G., and Barry III C.E. A glycolipid of hypervirulent tuberculosis strains that inhibits the innate immune response. Nature 431 (2004) 84
73. Manca C., Tsenova L., Barry III C.E., Bergtold A., Freeman S., Haslett P.A., Musser J.M., Freedman V.H., and Kaplan G. Mycobacterium tuberculosis CDC1551 induces a more vigorous host response in vivo and in vitro, but is not more virulent than other clinical isolates. J. Immunol. 162 (1999) 6740
74. Cowley S.C., and Elkins K.L. CD4+T cells mediate IFN-gamma-independent control of Mycobacterium tuberculosis infection both in vitro and in vivo. J. Immunol. 171 (2003) 4689
75. Tascon R.E., Stavropoulos E., Lukacs K.V., and Colston M.J. Protection against Mycobacterium tuberculosis infection by CD8 T cells requires production of gamma interferon. Infect. Immun. 66 (1998) 830
76. Scanga C.A., Mohan V.P., Yu K., Joseph H., Tanaka K., Chan J., and Flynn J.L. Depletion of CD4+T cells causes reactivation of murine persistent tuberculosis despite continued expression of IFN-gamma and NOS2. J. Exp. Med. 192 (2000) 347
77. De Libero G., Flesch I., and Kaufmann S.H.E. Mycobacteria-reactive Lyt-2+T cell lines. Eur. J. Immunol. 18 (1988) 59
78. Orme I., and Collins F. Adoptive protection of the Mycobacteria tuberculosis-infected lung. Cell Immunol. 84 (1984) 113